Skip to content

Chimeric 3C-RBD Recombinant COVID-19 Vaccines to Enhance Cellular Immunity

A novel COVID vaccine based on a recombinant chimer that is more soluble, stable and easier to produce

Published: 9th June 2021
Chimeric 3C-RBD Recombinant COVID-19 Vaccines to Enhance Cellular Immunity
insta_photos, stock.adobe.com
IP Status
  • No patent
Seeking
  • Seeking investment